Category Archives: Myocardial Infarction

MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. Continue reading →

Future Market Insights (FMI) presents its new, comprehensive study on the global Myocardial Infarction Therapeutics market spanning from 2016 to 2026. Researches at FMI have no left no stone unturned in bestowing readers a comprehensive view of the market, by studying the drivers, trends, challenges, and restraints. Backed by historical data and projected data, the report breaks down the vast study into numerous geographies and end-use segments, among others to condense the research Continue reading →

The global Myocardial Infarction Instrument market focuses on encompassing major statistical evidence for the Myocardial Infarction Instrument industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition the Myocardial Infarction Instrument study also shifts its attention with an in-depth competitive landscape, defined growth opportunities, market share coupled with product type and applications, key companies responsible for the production, and utilized strategies are also marked Continue reading →

Columns share an authors personal perspective. ***** The National Commission on COVID-19 and Criminal Justice issued its interim report looking at ways to reduce the pandemics impact on jails and prisons as well as the courts and law enforcement. The pandemic has consumed every facet of life across the country and around the world. Continue reading →

People with type 2 diabetes derive benefit from earlier detection and treatment, suggests a decade-long follow-up of the Anglo-Danish-Dutch Study in General Practice of Intensive Treatment and Complication Prevention in Type 2 Diabetic Patients Identified by Screening(ADDITION-Europe). "The 10-year follow-up findings support the use of intensive treatment of type 2 diabetes soon after diagnosis and have implications for policy relating to early detection and subsequent management of type 2 diabetes in primary care," said Simon Griffin, MD. Griffin, the study lead from the University of Cambridge, UK, presented the findings at the virtual European Association for the Study of Diabetes (EASD) Annual Meeting 2020. Continue reading →

Medtronic plc (NYSE:MDT), the global leader in medical technology,today announced it has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual-antiplatelet therapy (DAPT) labeling with an expanded indication for high bleeding risk (HBR)patients implanted with the Resolute Onyx DES. The Resolute Onyx DES is the first-and-only DES in the U.S. Continue reading →

Anticoagulants Market - Snapshot Anticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists, DTIs, and factor Xa inhibitors, are among the various anticoagulants available in the market. These are used for indications such as heart attack, stroke, deep venous thrombosis (DVT), pulmonary embolism (PE), surgery, angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction Continue reading →

NEW YORK, Sept. 29, 2020 /PRNewswire/ -- Patients with systemic lupus erythematosus (SLE) have a 27% higher risk of having a nonfatal cardiovascular disease (CVD) event compared to age- and sex-matched diabetes mellitus (DM) patients and more than twice the risk of the Medicaid general population, according to a new study led by a researcher at Hospital for Special Surgery (HSS) in New York City. Continue reading →

Introduction:The weekend effect in Polish myocardial infarction (MI) patients treated in the current network of cathlabs is poorly understood. Continue reading →

The case report aims to reveal de Winters electrocardiogram (ECG) pattern as an equivalent to anterior ST-segment elevation myocardial infarction (STEMI). We report a case of a 49-year-old man with a history of smoking who presented to the emergency department with a 1 day history of chest pain that was exacerbated 5 h prior to presentation Continue reading →